Literature DB >> 16013028

Synthesis of a dimeric Lewis antigen and the evaluation of the epitope specificity of antibodies elicited in mice.

Therese Buskas1, Yanhong Li, Geert-Jan Boons.   

Abstract

The Lewis(y)-Lewis(x) heptasaccharide, modified by an artificial aminopropyl spacer, was synthesized by an approach that employed two orthogonally protected lactosamine building blocks. A p-(benzoyl)-benzyl glycoside was used as a novel anomeric protecting group, which could be selectively removed at a late stage in the synthesis, thus offering the benefit of enhanced flexibility. The artificial aminopropyl moiety was modified by a thioacetyl group, which allowed an efficient conjugation to keyhole limpet hemocyanin (KLH) that had been activated with electrophilic 3-(bromoacetamido)-propionyl groups. Mice were immunized with the Le(y)Le(x)-BrAc-KLH antigen. Analysis of the sera by ELISA established that a strong helper T-cell immune response was raised against the Le(y)Le(x) saccharide. Further ELISA analysis showed that the titer for monomeric Le(y) tetrasaccharide was tenfold lower whereas recognition of the Le(x) trisaccharide was negligible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013028     DOI: 10.1002/chem.200500412

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  Comparative immunological studies of tumor-associated Lewis X, Lewis Y, and KH-1 antigens.

Authors:  Jiatong Guo; Wenjie Jiang; Qingjiang Li; Mohit Jaiswal; Zhongwu Guo
Journal:  Carbohydr Res       Date:  2020-03-31       Impact factor: 2.104

2.  Synthesis of the Cancer-Associated KH-1 Antigen by Block Assembly of Its Backbone Structure Followed by One-Step Grafting of Three Fucose Residues.

Authors:  Qingjiang Li; Zhongwu Guo
Journal:  Org Lett       Date:  2017-11-29       Impact factor: 6.005

3.  Recent Development in Carbohydrate Based Anti-cancer Vaccines.

Authors:  Zhaojun Yin; Xuefei Huang
Journal:  J Carbohydr Chem       Date:  2012-02-29       Impact factor: 1.667

Review 4.  Immunotherapy for cancer: synthetic carbohydrate-based vaccines.

Authors:  Therese Buskas; Pamela Thompson; Geert-Jan Boons
Journal:  Chem Commun (Camb)       Date:  2009-07-22       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.